| 2010-09-01 |
Epigenetics Therapeutics to 2017 - High Market Potential for Epigenetics Drugs in Acute Myeloid Leukemia, Multiple Myeloma and Cutaneous T-Cell Lymphoma |
GBI Research |
| 2010-08-01 |
Epigenetics: Tools, Diagnostics, Drugs and World Market |
Takeda Pacific |
| 2010-06-01 |
Epigenetic Drug & Diagnostic Pipelines: DNA Methylation, HDAC Inhibitors, and Emerging New Targets Report |
CHI Insight Pharma Reports |
| 2010-05-01 |
Epigenetic Drug & Diagnostic Pipelines |
CHI Insight Pharma Reports |
| 2009-01-13 |
The Epigenetics Healthcare R&D, Products and Commercial Implications |
Fuji-Keizai USA, Inc. |
| 2008-07-01 |
Cancer Personalized Medicine 2008 |
Select Biosciences Limited |
| 2008-05-01 |
Epigenetics and MicroRNA Diagnostics/Therapeutics 2008 |
Select Biosciences Limited |
| 2008-05-01 |
Systems Biology: A Disruptive Technology |
CHI Insight Pharma Reports |
| 2008-02-01 |
Epigenetics: Technologies, Applications, and the Commercial Landscape |
CHI Insight Pharma Reports |
| 2007-11-28 |
Premium Company Profile: Pharmion Corporation |
Datamonitor |
| 2007-03-01 |
Epigenomics: Emerging Opportunities in Biomarkers, Diagnostics and Therapeutics |
BCC Research |
| 2006-10-26 |
Companion Diagnostics: Enabling Personalized Medicines in Cancer |
Decision Resources |
